Sera Prognostics, Inc. SERA
2.04
(0.07)
(3.32%)
as of 25 Sep
- Market cap
- $83.2M
- P/E
- 0.0×
Follow SERA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1,312.40 | 1,789.92 | 1,735.84 | 1,595.23 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(14.56) | (11.63) | (22.97) | (23.40) | |
P/B ratio |
1.55 | 1.51 | 1.86 | 1.84 | |
Price to Tangible BV |
1.57 | 1.53 | 1.89 | 1.87 | |
EV/Sales |
648.93 | 958.36 | 1,251.90 | 1,139.42 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(1.64) | (2.03) | (3.96) | (4.20) | |
EV/FCF |
(1.59) | (1.91) | (3.70) | (3.98) | |
Quick Ratio |
1.91 | 2.02 | 1.62 | 1.84 | |
Current Ratio |
1.98 | 2.12 | 1.69 | 1.89 | |
Net Debt/EBITDA |
4.73 | 5.17 | 4.50 | 4.96 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.69 | 1.04 | 0.78 | 0.83 | |
Capex/Depreciation |
(0.27) | (0.04) | (1.35) | (0.46) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
11,643.33% | 21,642.86% | 32,160.00% | 20,525.00% | |
Selling, General and Administrative Expense of Revenue |
21,636.67% | 45,014.29% | 57,060.00% | 35,443.75% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
2,743.33% | 5,964.29% | 10,190.00% | 7,837.50% | |
Graham Net Nets |
0.23 | 0.23 | 0.10 | 0.12 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(36.81%) | (32.02%) | (23.05%) | (25.16%) | |
Free Cash Flow Yield |
(31.06%) | (28.05%) | (19.48%) | (17.96%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.12) | (0.17) | (0.13) | (0.13) | |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.00 | |
Free Cash Flow per Share |
(0.13) | (0.17) | (0.14) | (0.13) | |
Cash per Share |
0.92 | 0.94 | 0.82 | 0.87 | |
Shareholders Equity per Share |
1.18 | 1.35 | 1.58 | 1.66 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.18 | 1.35 | 1.58 | 1.66 | |
Free Cash Flow |
(6.36) | (8.78) | (6.45) | (6.59) | |
Working Capital |
23.78 | 26.31 | 16.58 | 20.99 | |
Capital Expenditures |
(0.05) | (0.01) | (0.33) | (0.11) | |
Net Current Asset Value |
20.78 | 23.80 | 14.25 | 18.55 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
1.73 | 0.57 | 33.00 | 7.00 | |
Net Profit Margin |
(30,463.33%) | (59,992.86%) | (78,810.00%) | (48,837.50%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.01 | 0.02 | 0.02 | 0.05 | |
Average Payables |
1.13 | 0.99 | 1.42 | 1.21 | |
Average Assets |
99.28 | 105.86 | 87.25 | 93.56 | |
Average Common Equity |
73.80 | 81.20 | 61.61 | 68.42 |
Columns are period end dates